lululemon athletica inc. Announces Participation in the Jefferies 2016 Consumer Conference
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq hits intraday record high on Alphabet boost, Mideast negotiation hopes
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Oppenheimer Remains Bullish on Lululemon Athletica (LULU) Following Solid 1Q Report
June 9, 2016 9:34 AM EDTOppenheimer maintained an Outperform rating and $80.00 price target on Lululemon Athletica Inc. (NASDAQ: LULU) following the company's 1Q earnings report. LULU reported EPS of $0.33, ahead of the Street's estimate of $0.31. Gross margins beat guidance by 130 bps, with upside coming from product margins, less occupancy deleverage and... More
Wedbush Remains Bullish on Lululemon Athletica (LULU) Following 1Q Report
June 9, 2016 8:24 AM EDTWedbush maintained an Outperform rating and $80.00 price target on Lululemon Athletica Inc. (NASDAQ: LULU) following the company's 1Q earnings report. Sales topped expectations, with SSS hitting +8% versus consensus of +6%. 2Q SSS guidance of +MSD falls in line with consensus of +5.5%. FY16 EPS was... More
UBS Raises Price Target on Lululemon Athletica (LULU) to $72 Following 1Q
June 9, 2016 8:10 AM EDTUBS reiterated a Neutral rating on Lululemon Athletica Inc. (NASDAQ: LULU), and raised the price target to $72.00 (from $69.00), following the company's 1Q and conference call. LULU noted that momentum has continued in early 2Q, particularly in terms of GM recovery, which provides more... More

